In 31 patients with primary aldosteronism routine clinical and laboratory data, the effect of orthostasis on plasma aldosterone (PA), plasma renin activity (PRA) and cortisol (PC), effect of fludrocortisone or high sodium intake on basal PA and night-day fluctuations of basal PA and PC with and without suppression of pituitary ACTH by dexamethasone were determined to differentiate patients with a unilateral aldosterone producing tumour (adenoma, APA, n = 20; carcinoma, CA, n = 1) from those with idiopathic bilateral adrenal hyperplasia (IAH, n= 10). Mean systolic and diastolic blood pressure, age, serum sodium, serum potassium and urinary excretion of sodium and potassium were not significantly different in both groups of patients. Normokalaemic primary aldosteronism occurred both in patients with APA (n = 2) and in patients with IAH (n = 1). Mean basal PA and mean urinary excretion rate of aldosterone-18-glucuronide were higher though not significantly different in patients with APA or CA than in those with IAH. A substantial number of the patients with APA (n = 5) and with IAH (n = 3) showed urinary excretion rates of aldosterone-18-glucuronide [2266] 13 \g=m\g/24h. Dedicated to Prof. R. Ortmann on the occasion of his 65th birthday. O
Mean PA and PRA significantly increased (P < 0.025) in patients with IAH in response to posture. However, these changes also occurred at times in some patients with APA.
Both fludrocortisone and high sodium intake produced a variable and no group-specific effect on basal PA. An adrenal adenoma may be localized by adrenal venography (Bucht 1962: Kahn et cd. 1971) determination of aldosterone in both adrenal veins (Melby et al. 1967) or by [131I]choIesterol-scintigraphy Blair et al. 1971 ). However, with the exception of [mI] cholesterol-scintigraphy these procedures are invasive and as to adrenal venography seem to bear a certain risk in precipitating adrenal crisis (Bayliss et al. 1970; Jorgenson 8c Stiris 1974). Therefore, attempts to distinguish an adrenal adenoma from bilateral hyperplasia by means of analysing aldosterone. cortisol and/or renin activity in peripheral vein blood seemed promising.
In the past differential diagnosis was made: 1. clinical and routine labora¬ tory data (Ferris et al. 1970; Aitchison et al. 1971) . 2. actual level of basal (supine) plasma aldosterone (Biglieri et al. 1974) , 3 . effect of orthostasis on aldosterone and cortisol (Ganguly et al. 1973; Vetter 8c Vetter 1975; Schambelan et al. 1976) , and 4. circadian rhythmicity of aldosterone, cortisol and renin activity (Vetter et al. 1974; Vetter 8c Vetter 1975; Schambelan et al. 1976) . However, these studies often included only a few patients which made it dif¬ ficult to interpret the results as being characteristic for an adrenal adenoma or for bilateral adrenal hyperplasia.
PATIENTS AND METHODS

Patients
Thirty-one patients were included in the study.
In 20 of these patients a unilateral adrenal adenoma (14 of the left and 6 of the right adrenal gland) was found at operation. One patient showed a carcinoma of the left adrenal gland. Ten patients were classified as having bilateral idiopathic adrenal hyperplasia.
One of these patients was totally adrenalectomized. The remaining 9 patients under¬ went unilateral adrenalectomy. These patients showed reoccurrence of abnormal high peripheral aldosterone levels within 1 year after surgery.
Pre-operatively the patients were examined under the following conditions: Night-day rhythm with suppression of ACTH by dexamethasone Both in the group of patients with adenoma (cases 12-21) and in the group with hyperplasia (cases 22-27) a variable effect of dexamethasone on PA curves was observed (Fig. 4) .
Oral administration of dexamethasone produced in 7 of the 10 patients with adenoma (cases 12-14, 18-21) a marked suppression of PA values. How¬ ever, no or only a minimal effect of dexamethasone was observed in the re¬ maining 3 patients with adenoma (cases 15-17).
In 3 of the 6 patients with bilateral adrenal lesions (cases 22, 23, 25) dexa¬ methasone reduced basal PA levels, whereas in the remaining 3 patients (cases 24, 26, 27 ) no or only a slight effect of dexamethasone could be de¬ monstrated.
In all patients PC was with a few exceptions below 2 «g/lOO ml indicating total suppression of endogenous ACTH. Tables 1 and 2 .
DISCUSSION
The main symptom of primary aldosteronism is hypokalaemia which is said to be more severe in patients with adenoma than in those with bilateral adrenal lesions (Ferris et al. 1970; Aitchison et al. 1971) . However, in this study mean serum potassium was almost identical in both groups of patients.
The finding of normal serum potassium levels in about 10°/o of our patients agrees with a recent report of Ferris et al. (1978) . (Schambelan et al. 1976 ), whereas in a previous study we failed to demonstrate a constant fall in plasma aldosterone in patients with adenoma (Vetter 8c Vetter 1975) . In this study a significant change (in¬ crease) in aldosterone was only observed in the group of patients with hyper¬ plasia.
In patients with hyperplasia several investigators have observed a subnor¬ mal supine PRA but not as low as in patients with an adenoma and slight increases in PRA with upright posture (Baer et al. 1970; Stockight et al. 1971 ). As to the increase of PRA this is in good agreement with our results showing a statistically significant rise of PRA in patients with hyperplasia.
Since, however, a few patients with adenoma showed normal supine and upright PRA values the nature of the underlying adrenocortical pathology In a recent study Ganguly et al. (1977) noticed a transient fall and a sub¬ sequent return of elevated aldosterone plasma concentrations during continued administration of dexamethasone in 5 patients with adenoma. In a single patient Katz et al. (1975) found no effect on plasma aldosterone following 3 days medication with dexamethasone.
The results reported in this study were obtained within 8-24 h after ini¬ tiation of dexamethasone therapy. In the majority of patients with adenoma dexamethasone reduced plasma aldosterone levels and either abolished or at¬ tenuated secretory episodes of aldosterone. However, in 3 of the 10 patients with adenoma plasma aldosterone curves were not affected by dexamethasone. In 3 of 4 patients with bilateral adrenal lesions whose plasma aldosterone and cortisol values were positively correlated dexamethasone reduced plasma aldosterone. In the remaining 3 patients with hyperplasia no or only a mini¬ mal effect of dexamethasone on plasma aldosterone could be demonstrated. Because both groups of patients showed a variable response to dexametha¬ sone, analysis of the effect of short-term pre-treatment with this steroid did not differentiate patients with adenoma from those with hyperplasia.
